Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!

Andreas Cerny

doi:10.4414/smw.2015.14231

Viewpoint

Vol. 145 No. 5152 (2015)

Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!

Andreas Cerny

DOI: https://doi.org/10.4414/smw.2015.14231
Cite this as:: Swiss Med Wkly. 2015;145:w14231
Published: 13.12.2015

References

Frey RS, Boldanova T, Heim M. Ultrasound surveillance for hepatocellular carcinoma: real-life performance in a hepatology outpatient clinic. Swiss Med Wkly. 2015;145:w14200. http://www.smw.ch/content/smw-2015-14200/
Dufour J-F, Bordoni A, Lorez M and the NICER Working Group. Trends in hepatic cancer survival in Switzerland. Schweizer Krebsbulletin. 2014;1:46–50.
Trinchet J-C, Bourcier V, Chaffaut C, Ahmed MA, Alam S, Marcellin P, et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir Prospective Cohort) Hepatology. 2015;62:737–50.
Cebolla B, Björnberg. Health Consumer Powerhouse: Euro Hepatitis Index 2012 Report ISBN 978-91-980687-0-2.
Al Hasani F, Knoepfli M, Gemperli A, Kollar A, Banz V, Kettenbach J, et al. Annals of Hepatol. 2014;12(2):204–10.
Fretz R, Negro F, Bruggmann P, Lavanchy, De Gottardi A, Pache I, et al. Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss Med Wkly. May 17;143:w13793. doi: 10.4414/smw.2013.13793.

How to Cite

1.

Cerny A. Screening for liver cancer in high risk patients in Switzerland: Yes, it works, but No, we do not do it systematically!. Swiss Med Wkly [Internet]. 2015 Dec. 13 [cited 2024 Apr. 19];145(5152):w14231. Available from: https://smw.ch/index.php/smw/article/view/2129

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Most read articles by the same author(s)

Rainer Fretz, Francesco Negro, Philip Bruggmann, Daniel Lavanchy, Andrea De Gottardi, Isabelle Pache, Virginie Masserey Spicher, Andreas Cerny, Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection , Swiss Medical Weekly: Vol. 143 No. 1920 (2013)
Nicolas Goossens, Stefano Bellentani, Andreas Cerny, Jean-Francois Dufour, François R. Jornayvaz, Joachim Mertens, Alberto Moriggia, Beat Muellhaupt, Francesco Negro, Homie Razavi, David Semela, Chris Estes, Nonalcoholic fatty liver disease burden – Switzerland 2018–2030 , Swiss Medical Weekly: Vol. 149 No. 5152 (2019)
Christine Ludz, Guido Stirnimann, David Semela, Joachim Mertens, Andreas E. Kremer, Magdalena Filipowicz Sinnreich, Christiane Sokollik, Christine Bernsmeier, Solange Bresson-Hadni, Valérie McLin, Nathalie Rock, Christian Braegger, Carsten Posovszky, Pascal Müller, Matthias Cremer, Andrea De Gottardi, Antonio Galante, Raoul Furlano, Franziska Righini-Grunder, Björn Becker, Stephan Böhm, Klaas Heyland, Andreas Nydegger, Costanzo Limoni, Diego Vergani, Giorgina Mieli-Vergani, Claudia Di Bartolomeo, Andreas Cerny, Benedetta Terziroli Beretta-Piccoli, Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study , Swiss Medical Weekly: Vol. 153 No. 8 (2023)
Lorenz Kuske, Armand Mensen, Beat Müllhaupt, Francesco Negro, David Semela, Darius Moradpour, Pierre Jean Malé, Markus H Heim, Raffaele Malinverni, Andreas Cerny, Jean-Francois Dufour, Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma , Swiss Medical Weekly: Vol. 142 No. 3132 (2012)
Darius Moradpour, Andreas Cerny, Markus H. Heim, Hubert E. Blum, Hepatitis C: an update , Swiss Medical Weekly: Vol. 131 No. 2122 (2001)
Andreas Cerny, Raoul Blindenbacher, Alberto Moriggia, Controlling HCV in Switzerland: running against the clock , Swiss Medical Weekly: Vol. 149 No. 1112 (2019)

[1] Frey RS, Boldanova T, Heim M. Ultrasound surveillance for hepatocellular carcinoma: real-life performance in a hepatology outpatient clinic. Swiss Med Wkly. 2015;145:w14200. http://www.smw.ch/content/smw-2015-14200/

[2] Dufour J-F, Bordoni A, Lorez M and the NICER Working Group. Trends in hepatic cancer survival in Switzerland. Schweizer Krebsbulletin. 2014;1:46–50.

[3] Trinchet J-C, Bourcier V, Chaffaut C, Ahmed MA, Alam S, Marcellin P, et al. Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir Prospective Cohort) Hepatology. 2015;62:737–50.

[4] Cebolla B, Björnberg. Health Consumer Powerhouse: Euro Hepatitis Index 2012 Report ISBN 978-91-980687-0-2.

[5] Al Hasani F, Knoepfli M, Gemperli A, Kollar A, Banz V, Kettenbach J, et al. Annals of Hepatol. 2014;12(2):204–10.

[6] Fretz R, Negro F, Bruggmann P, Lavanchy, De Gottardi A, Pache I, et al. Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection. Swiss Med Wkly. May 17;143:w13793. doi: 10.4414/smw.2013.13793.